Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 02:08PM ET
1.55
Dollar change
+0.08
Percentage change
5.68
%
Index- P/E- EPS (ttm)-0.98 Insider Own7.80% Shs Outstand21.65M Perf Week-9.68%
Market Cap33.63M Forward P/E- EPS next Y-0.71 Insider Trans0.00% Shs Float19.96M Perf Month-12.23%
Income-12.73M PEG- EPS next Q-0.20 Inst Own6.55% Short Float5.63% Perf Quarter63.53%
Sales1.09M P/S30.86 EPS this Y3.12% Inst Trans4.65% Short Ratio1.59 Perf Half Y39.95%
Book/sh0.65 P/B2.38 EPS next Y24.01% ROA-72.99% Short Interest1.12M Perf Year30.55%
Cash/sh0.40 P/C3.87 EPS next 5Y- ROE-89.50% 52W Range0.25 - 4.75 Perf YTD59.33%
Dividend Est.- P/FCF- EPS past 5Y- ROI-100.94% 52W High-67.29% Beta-3.00
Dividend TTM- Quick Ratio4.40 Sales past 5Y9.21% Gross Margin-15.80% 52W Low526.66% ATR (14)0.22
Dividend Ex-Date- Current Ratio4.68 EPS Y/Y TTM-6.40% Oper. Margin-1194.70% RSI (14)46.31 Volatility9.71% 14.48%
Employees34 Debt/Eq0.27 Sales Y/Y TTM-10.86% Profit Margin-1164.65% Recom1.00 Target Price9.25
Option/ShortNo / Yes LT Debt/Eq0.21 EPS Q/Q-4.87% Payout- Rel Volume0.78 Prev Close1.47
Sales Surprise-13.02% EPS Surprise-19.54% Sales Q/Q-29.67% EarningsNov 14 BMO Avg Volume705.26K Price1.55
SMA20-15.62% SMA5012.70% SMA20057.40% Trades Volume403,604 Change5.68%
Mar-21-24 09:00AM
Mar-20-24 08:15AM
Mar-13-24 09:00AM
Mar-06-24 09:00AM
Feb-28-24 09:00AM
08:30AM Loading…
Feb-06-24 08:30AM
Jan-26-24 08:00AM
Jan-23-24 08:30AM
Dec-15-23 08:30AM
Nov-30-23 08:30AM
Nov-28-23 05:27PM
08:30AM
Nov-23-23 03:38PM
Nov-15-23 08:30AM
07:30AM
07:00AM Loading…
Nov-14-23 07:00AM
Oct-30-23 02:02PM
Oct-26-23 08:30AM
Oct-25-23 08:00AM
Oct-24-23 04:13AM
Oct-11-23 07:00AM
Oct-04-23 08:30AM
Oct-03-23 08:30AM
Oct-02-23 07:08PM
Sep-27-23 08:00AM
Sep-25-23 05:25PM
Sep-20-23 08:30AM
Sep-06-23 08:30AM
Aug-31-23 08:30AM
Aug-10-23 08:00AM
08:45AM Loading…
Aug-03-23 08:45AM
Jul-27-23 08:45AM
Jul-03-23 09:55AM
Jun-26-23 08:00AM
Jun-15-23 08:00AM
Jun-14-23 08:00AM
Jun-08-23 08:30AM
May-11-23 04:05PM
08:30AM
May-03-23 08:30AM
May-01-23 04:05PM
Apr-19-23 08:00AM
Apr-18-23 08:00AM
Mar-30-23 08:00AM
Mar-09-23 08:00AM
Dec-19-22 09:00AM
Dec-12-22 08:30AM
Nov-29-22 07:00AM
Nov-21-22 08:30AM
Nov-12-22 08:17AM
Nov-10-22 09:55AM
08:44AM
Oct-20-22 08:00AM
Oct-14-22 04:05PM
Oct-12-22 08:00AM
Oct-06-22 08:01AM
Sep-29-22 08:00AM
Sep-01-22 04:05PM
Aug-10-22 05:45PM
04:05PM
Aug-03-22 08:00AM
Jul-20-22 07:00AM
Jul-11-22 08:30AM
Jul-06-22 08:00AM
Jun-28-22 05:31PM
Jun-15-22 08:00AM
May-21-22 10:19AM
May-11-22 04:05PM
Mar-25-22 08:00AM
Mar-24-22 04:05PM
Feb-24-22 08:00AM
Feb-01-22 08:30AM
Jan-31-22 04:24AM
Jan-20-22 08:00AM
Dec-23-21 08:05AM
Nov-10-21 04:05PM
Sep-23-21 05:46PM
Sep-20-21 04:05PM
Sep-18-21 09:31AM
Sep-01-21 04:05PM
Aug-11-21 04:05PM
Jul-20-21 08:31AM
Jul-19-21 10:35AM
Jun-21-21 08:49AM
Jun-18-21 05:19PM
Femasys, Inc. is a biomedical company, which engages in the development of novel solutions for reproductive healthcare. The company was founded by Kathy Lee-Sepsick in 2004 and is headquartered in Suwanee, GA.